UPDATE: Citi Downgrades Harpoon Therapeutics (HARP) to Neutral
Tweet Send to a Friend
(Updated - June 8, 2021 5:56 AM EDT)
Citi analyst Yigal Nochomovitz downgraded Harpoon Therapeutics (NASDAQ: HARP) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Yigal Nochomovitz downgraded Harpoon Therapeutics (NASDAQ: HARP) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
